CC
IBB icon

Centiva Capital’s iShares Biotechnology ETF IBB Stock Holding History

Centiva Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,600
Closed -$608K – 1803
2024
Q4 		$608K Sell
4,600
-4,800
-51% -$675K 0.01% 715
2024
Q3 		$1.37M Sell
9,400
-25,800
-73% -$3.73M 0.03% 663
2024
Q2 		$4.83M Buy
+35,200
New +$4.7M 0.08% 161
2024
Q1 		– Sell
-2,400
Closed -$326K – 1971
2023
Q4 		$326K Buy
+2,400
New +$293K 0.01% 1166
2021
Q1 		– Sell
-75,000
Closed -$11.4M – 1267
2020
Q4 		$11.4M Hold
75,000
– – 0.44% 39
2020
Q3 		$10.2M Hold
75,000
– – 0.67% 24
2020
Q2 		$10.3M Sell
75,000
-244,900
-77% -$31.2M 0.62% 24
2020
Q1 		$34.5M Buy
319,900
+71,400
+29% +$8.22M 1.55% 6
2019
Q4 		$30M Buy
248,500
+244,900
+6,803% +$27.3M 1.46% 11
2019
Q3 		$358K Sell
3,600
-1,400
-28% -$147K 0.02% 401
2019
Q2 		$546K Sell
5,000
-5,000
-50% -$532K 0.03% 256
2019
Q1 		$1.12M Sell
10,000
-4,400
-31% -$483K 0.08% 169
2018
Q4 		$1.39M Buy
14,400
+10,000
+227% +$1.06M 0.11% 122
2018
Q3 		$536K Buy
+4,400
New +$518K 0.05% 126

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Centiva Capital's IBB Position: Q2 2026 in Review

Centiva Capital sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 3,000 shares — an estimated $507K sold.

Centiva Capital first reported a position in IBB in Q4 2018 and held it in 13 quarters. The position peaked at $17.6M in Q1 2020. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Centiva Capital reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 3,000 iShares Biotechnology ETF shares in Q2 2026, an estimated $507K.
  • Centiva Capital first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 13 quarters.
  • Centiva Capital's iShares Biotechnology ETF position peaked at $17.6M in Q1 2020.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.